Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, 2-5-1 Shikata-cho, Kitaku, Okayama 700-8558, Japan.
Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
Int J Mol Sci. 2020 Jan 30;21(3):913. doi: 10.3390/ijms21030913.
The serine proteases kallikrein-related peptidase (KLK) 5 and KLK7 cleave cell adhesion molecules in the epidermis. Aberrant epidermal serine protease activity is thought to play an important role in the pathogenesis of atopic dermatitis (AD). We collected the stratum corneum (SC) from healthy individuals (n = 46) and AD patients (n = 63) by tape stripping and then measuring the trypsin- and chymotrypsin-like serine protease activity. We also analyzed the p.D386N and p.E420K of SPINK5 variants and loss-of-function mutations of FLG in the AD patients. The serine protease activity in the SC was increased not only in AD lesions but also in non-lesions of AD patients. We found, generally, that there was a positive correlation between the serine protease activity in the SC and the total serum immunoglobulin E (IgE) levels, serum thymus and activation-regulated chemokine (TARC) levels, and peripheral blood eosinophil counts. Moreover, the p.D386N or p.E420K in SPINK5 and FLG mutations were not significantly associated with the SC's serine protease activity. Epidermal serine protease activity was increased even in non-lesions of AD patients. Such activity was found to correlate with a number of biomarkers of AD. Further investigations of serine proteases might provide new treatments and prophylaxis for AD.
丝氨酸蛋白酶激肽释放酶相关肽酶 (KLK)5 和 KLK7 在表皮中裂解细胞黏附分子。表皮丝氨酸蛋白酶活性异常被认为在特应性皮炎 (AD) 的发病机制中起重要作用。我们通过胶带剥离从健康个体 (n = 46) 和 AD 患者 (n = 63) 中收集角质层 (SC),然后测量胰蛋白酶和糜蛋白酶样丝氨酸蛋白酶活性。我们还分析了 AD 患者 SPINK5 变异体的 p.D386N 和 p.E420K 以及 FLG 的功能丧失突变。SC 中的丝氨酸蛋白酶活性不仅在 AD 病变中增加,而且在 AD 患者的非病变中也增加。我们发现,SC 中的丝氨酸蛋白酶活性通常与总血清免疫球蛋白 E (IgE) 水平、血清胸腺和激活调节趋化因子 (TARC) 水平以及外周血嗜酸性粒细胞计数呈正相关。此外,SPINK5 中的 p.D386N 或 p.E420K 和 FLG 突变与 SC 的丝氨酸蛋白酶活性没有显著相关性。AD 患者的非病变部位也增加了表皮丝氨酸蛋白酶活性。这种活性与 AD 的许多生物标志物相关。对丝氨酸蛋白酶的进一步研究可能为 AD 提供新的治疗和预防方法。